CN109355253A - Culture medium used in the cultural method and this method that inducing umbilical cord mesenchymal stem breaks up at rouge - Google Patents

Culture medium used in the cultural method and this method that inducing umbilical cord mesenchymal stem breaks up at rouge Download PDF

Info

Publication number
CN109355253A
CN109355253A CN201811410285.0A CN201811410285A CN109355253A CN 109355253 A CN109355253 A CN 109355253A CN 201811410285 A CN201811410285 A CN 201811410285A CN 109355253 A CN109355253 A CN 109355253A
Authority
CN
China
Prior art keywords
cell
culture medium
culture
umbilical cord
mesenchymal stem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201811410285.0A
Other languages
Chinese (zh)
Inventor
刘年
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Taidong Biotechnology Co Ltd
Original Assignee
Beijing Taidong Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Taidong Biotechnology Co Ltd filed Critical Beijing Taidong Biotechnology Co Ltd
Priority to CN201811410285.0A priority Critical patent/CN109355253A/en
Publication of CN109355253A publication Critical patent/CN109355253A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0653Adipocytes; Adipose tissue
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30Hormones
    • C12N2501/33Insulin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/13Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
    • C12N2506/1346Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells
    • C12N2506/1369Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells from blood-borne mesenchymal stem cells, e.g. MSC from umbilical blood

Abstract

The present invention relates to cell Fiber differentiation technical field, culture medium used in the cultural method and this method that break up in particular to a kind of inducing umbilical cord mesenchymal stem at rouge.The culture medium is obtained by least additionally adding following component in basal medium: 0.7~1.3 μm of ol/L of dexamethasone, 40~60 μ g/mL of 400~600 μm of ol/L, IBMX0.3~0.7mmol/L of Indomethacin, 7~13 μm of ol/L of insulin and acid ascorbyl ester.The present invention cooperates specific cultural method by optimization inducing component, improves induced velocity and efficiency, induced efficiency is high i.e. it can be seen that a large amount of intracellular fat drips are formed within 5~7 days.With induction time, fat drips are become larger, and illustrate that lipoblast function is good.It dyes within 12~14 days, it can be seen that very classical red oil droplet.

Description

The cultural method and this method institute that inducing umbilical cord mesenchymal stem breaks up at rouge Culture medium
Technical field
The present invention relates to cell Fiber differentiation technical fields, in particular to a kind of inducing umbilical cord mesenchymal stem Culture medium used in cultural method and this method at rouge differentiation.
Background technique
Mescenchymal stem cell (mesenchymal stem cells, MSC) be mesoderma origin, have height self more The multipotential stem cell of new ability and multi-lineage potential.In fact, MSC is widely present in whole body Various Tissues, almost source In all histoorgans of body, such as marrow, periosteum, adipose tissue, dental pulp, synovial membrane, umbilical cord, placenta, amniotic fluid and fetal tissue Deng.The mescenchymal stem cell of separate sources has similar form, expresses identical surface markers, has similar biological characteristics Property aspect, can such as cultivate amplification in vitro, and can be divided under given conditions thin including nerve cell, osteoblast, cartilage The cell of more organization systems including born of the same parents, muscle cell, fat cell.MSC in addition to multidirectional histocyte differentiation capability it Outside, important regulative also is played in hematopoiesis, immunization inflammatory reaction, angiogenesis et al. body critical function.
Umbilical cord mesenchymal stem cells, which refer to, is present in one of neonatal umbilical cord tissue versatile stem cell.It is filled between umbilical cord Matter is a kind of low immunogenicity cell, and has very strong immunoloregulation function.Umbilical cord mesenchymal stem cells possess the whole of MSC Characteristic, and rich content are easily isolated culture.
Compared with the MSC in other sources, UC-MSC is more original, is dry between embryonic stem cell and adult stem cell Cell, proliferation is lower than embryonic stem cell with differentiation capability, but is apparently higher than adult stem cell.
Umbilical cord mesenchymal stem cells have more differentiation potentials, and under specific inductive condition, UC-MSC can not only be divided into The mesoblastemas such as bone, cartilage, fat, tendon, and can inwardly embryonic tissue cell (such as cardiac muscle cell, liver cell) and outside Embryonic tissue cell (such as nerve cell) differentiation.UC-MSC does not have oncogenicity, can different inductive condition and it is suitable in vivo It grows in microenvironment, safely directed differentiation is different tissue lines, has the ability for repairing various tissues and organ.
It is the complex process controlled by many factors that umbilical cord mesenchymal stem cells, which are induced differentiation into fat cell, is had Multiple genes participate in regulation, and the differentiation at rouge direction is and the result that is activated at a series of relevant transcription factors of rouge.The factor Mainly have: Rev-erb-a, NOTCH, Kruppe1 like factor -15 (KLF150, liver X receptor (LXRs0,3- Hydroxymethylglutaryl list Acyl CoA synthase (HMCS), cAMP-responsive element binding protein/antibody (CREB), STAT etc..
At fatty stimulant also there are many kinds of, in the medium add dexamethasone, the urgent xanthine of 3- isobutyl group -1- (IBMX), insulin and indocin etc. can induce umbilical cord mesenchymal stem cells to Adipose Differentiation.
Umbilical cord mesenchymal stem cells are that mescenchymal stem cell one differentiation relatively difficult to achieve is tested at rouge differentiation, induction group Divide and the formation of fat cell is had significant effect.Current inductive technology, it is extremely low at rouge differentiation rate, only filled between only a few Matter stem cell can break up lipoblast, form fat drips, remaining most cells can not form fat drips always.
The size of fat drips is also to judge into the evaluation index of rouge differentiation superiority and inferiority, and most of method of inducing differentiation can be only formed pole Small distributed fat drips illustrate that culture scheme can not be that mescenchymal stem cell sufficiently breaks up lipoblast.
In view of this, the present invention is specifically proposed.
Summary of the invention
It is a primary object of the present invention to be induced to differentiate into fat induction in the process by optimizing umbilical cord mesenchymal stem cells Break up component, improve speed and ratio that umbilical cord mesenchymal stem cells are divided into fat cell, improves fat cell after inducing Quality.
In order to realize above-mentioned purpose of the invention, the following technical scheme is adopted:
The present invention relates to the culture medium that a kind of inducing umbilical cord mesenchymal stem breaks up at rouge, by basal medium extremely Following component is additionally added less to obtain:
0.7~1.3 μm of ol/L of dexamethasone, Indomethacin 400~600 μm of ol/L, IBMX0.3~0.7mmol/L, pancreas islet 40~60 μ g/mL of element 7~13 μm of ol/L and acid ascorbyl ester.
According to another aspect of the present invention, the invention further relates to a kind of inducing umbilical cord mesenchymal stems into rouge differentiation side Method, comprising:
Use culture medium culture umbilical cord mesenchymal stem cells as described above.
Compared with prior art, the invention has the benefit that
The present invention cooperates specific cultural method, improves induced velocity and efficiency by optimization inducing component, and 5~7 days I.e. it can be seen that a large amount of intracellular fat drips are formed, induced efficiency is high.With induction time, fat drips are become larger, and it is thin to be illustrated as rouge Born of the same parents' function is good.It dyes within 12~14 days, it can be seen that very classical red oil droplet.
Detailed description of the invention
It, below will be to specific in order to illustrate more clearly of the specific embodiment of the invention or technical solution in the prior art Embodiment or attached drawing needed to be used in the description of the prior art be briefly described, it should be apparent that, it is described below Attached drawing is some embodiments of the present invention, for those of ordinary skill in the art, before not making the creative labor It puts, is also possible to obtain other drawings based on these drawings.
Fig. 1 is the Oil red O stained photographs of fat cell cultivated in one embodiment of the invention, × 10;
Fig. 2 is the Oil red O stained photographs of fat cell cultivated in one embodiment of the invention, × 20;
Fig. 3 is the Oil red O stained photographs of fat cell cultivated in one embodiment of the invention, × 40.
Specific embodiment
The present invention relates to the culture medium that a kind of inducing umbilical cord mesenchymal stem breaks up at rouge, by basal medium extremely Following component is additionally added less to obtain:
0.7~1.3 μm of ol/L of dexamethasone, Indomethacin 400~600 μm of ol/L, IBMX0.3~0.7mmol/L, pancreas islet 40~60 μ g/mL of element 7~13 μm of ol/L and acid ascorbyl ester.
In some embodiments, it is obtained by least additionally adding following component in basal medium:
0.8~1.2 μm of ol/L of dexamethasone, Indomethacin 450~550 μm of ol/L, IBMX0.4~0.6mmol/L, pancreas islet 45~55 μ g/mL of element 8~12 μm of ol/L and acid ascorbyl ester.
In some embodiments, it is obtained by least additionally adding following component in basal medium:
1 μm of ol/L of dexamethasone, 500 μm of ol/L, IBMX0.5mmol/L of Indomethacin, 10 μm of ol/L of insulin and anti- Bad 50 μ g/mL of hematic acid ester.
In some embodiments, the basal medium is DMEM low sugar culture medium;
In some embodiments, in the DMEM low sugar culture medium containing 8%~12%FBS and 0.08%~ 0.12% glutamine.
DMEM low sugar culture medium may be selected to be 86%~92% low sugar DMEM, and it is dry that low sugar culture medium is suitable for umbilical cord mesenchyma Differentiation of the cell to fat cell.
According to another aspect of the present invention, the invention further relates to a kind of inducing umbilical cord mesenchymal stems into rouge differentiation side Method, comprising:
Use culture medium culture umbilical cord mesenchymal stem cells as described above.
It in some embodiments, is P3~P5 generation for the umbilical cord mesenchymal stem cells of inoculation, cell confluency degree is 70%~80% and cell in good condition collect and obtain after digesting.
The umbilical cord mesenchymal stem cells growth of this cultivation stage rapidly, is conducive to differentiation culture.
In some embodiments, pancreas enzyme concentration used by the digestion is 0.20%~0.30%;It is also an option that 0.25%.
In some embodiments, it is completed in digestion, after cleaning cell, cell is moved into ventilative sharp floor cells culture tube In, supernatant liquid is removed after centrifugation.
In some embodiments, in culture, the inoculum concentration of cell is every 2mL culture medium inoculated (1~5) × 104It is a Cell.
In some embodiments, the inoculum concentration of cell is every 2mL culture medium inoculated (2~4) × 104A cell;Or 3 × 104A cell.
In some embodiments, the time of the culture is 12~14 days, it is also an option that 13 days;
In some embodiments, it changes the liquid once within every 2~4 days.
Embodiment of the present invention is described in detail below in conjunction with embodiment, but those skilled in the art will Understand, the following example is merely to illustrate the present invention, and is not construed as limiting the scope of the invention.It is not specified in embodiment specific Condition person carries out according to conventional conditions or manufacturer's recommended conditions.Reagents or instruments used without specified manufacturer is It can be with conventional products that are commercially available.
Embodiment 1
1. inducing component
2. the preparation of induced medium
1) basal medium of induction differentiation is 89% low sugar DMEM, 10%FBS fetal calf serum and 1% glutamine.Its Glutamine faces used time addition.
2) with prepare the complete induced medium of 100mL calculate inducing component dexamethasone, Indomethacin, IBMX, insulin, The dosage of acid ascorbyl ester is dispensed with sterile 0.5mLEP pipe, -20 DEG C of preservations.All components are kept in dark place.
3) by the basal medium of required volume, dexamethasone, Indomethacin, IBMX, insulin, ascorbic acid when preparing Ester takes out, and mixes after dissolving, is made into complete medium, can 4 DEG C of preservation 5-7d.
3. inducing differentiation step
1) T75 bottles of inoculations are taken, in P3-P5 generation, covers with to 70-80% and in good condition one bottle of umbilical cord mesenchymal stem cells, Pipette sucks culture medium, and 2mLPBS is added, and gently spin rinse falls remaining culture medium.
2) 0.25% pancreatin that 1mL shifts to an earlier date equilibrium at room temperature is added, gently rotation is uniformly distributed pancreatin.Lay flat static 1- 2min or so lifts culture bottle and visually observes whether adherent cell is mottled to fall off under lamp.It, can be gently if digestion process is slower Culture bottle side wall is patted, cell detachment is accelerated by vibration.
3) cell is substantially all fall off after, be added 1mL serum, rotation mixing terminate pancreatin digestion.It is added 10mLPBS collects cell, and the cell of collection is transferred in 50mL centrifuge tube.10mLPBS is added again, rotating and culturing bottle is received Collect remaining cell.
4) it is placed in a centrifuge, trim, 1000rpm is centrifuged 5min, gently sucks supernatant.20mLPBS is added again 1000rpm is centrifuged 5min, gently sucks supernatant.
5) cell is resuspended in 10mL basal medium, is counted with cell counting board, calculates cell density.
6) 3 × 10 are taken4Umbilical cord mesenchymal stem cells in diameter 9cm Tissue Culture Dish, basal medium is added to end Volume 2ml, shaking gently culture dish is uniformly distributed cell in entire culture dish.
7) Tissue Culture Dish is gently placed in CO2In incubator, culture overnight keeps cell adherent.
8) it siphons away basal medium within second day, 2mL induced medium is gently added, to start to induce D0.
9) it changes the liquid once within every 3 days, while observing cell state.
5-7 days i.e. it can be seen that fat drips are formed.
12-14 days part fat drips are very big, should be dyed at this time, if delay fat drips may rupture.
Embodiment 2
1. inducing component
2. the preparation of induced medium
With embodiment 1.
3. inducing differentiation step
With embodiment 1.
Embodiment 3
1. inducing component
Title Content
Dexamethasone 0.9μmol/L
Indomethacin 550μmol/L
IBMX 0.6mmol/L
Insulin 11μmol/L
Acid ascorbyl ester 45μg/mL
2. the preparation of induced medium
With embodiment 1.
3. inducing differentiation step
With embodiment 1.
Embodiment 4
1. inducing component
Title Content
Dexamethasone 1μmol/L
Indomethacin 500μmol/L
IBMX 0.5mmol/L
Insulin 10μmol/L
Acid ascorbyl ester 50μg/mL
2. the preparation of induced medium
With embodiment 1.
3. inducing differentiation step
With embodiment 1.
Experimental example
Resulting fat cell is broken up to the culture of embodiment 4 and carries out oil red O stain identification.
1) by the neutral filter paper filtering of oil red O working solution, remove impurity therein.
2) induced medium in culture dish is siphoned away, 2mLPBS is gently added and rinses 2 times.
3) the fixed 30min of the center 2mL4% formaldehyde is added, sucks formaldehyde, 2mLPBS is gently added and rinses 2 times.
4) 1mL oil red O working solution is added, dyes 30min.
5) oil red O dye liquor is siphoned away, is cleaned 2 times with 1mLPBS.
6) microscopically observation is taken pictures.
Result of taking pictures is as shown in Figures 1 to 3.It can see by microscope macrograph, umbilical cord mesenchymal stem cells are in large quantities It is divided into lipoblast, differentiation ratio is very high.High power lens photo can see with the presence of a large amount of big fat drips, be illustrated as rouge point Change state is very good.
Finally, it should be noted that the above embodiments are only used to illustrate the technical solution of the present invention., rather than its limitations;To the greatest extent Present invention has been described in detail with reference to the aforementioned embodiments for pipe, but those skilled in the art should understand that: its It is still possible to modify the technical solutions described in the foregoing embodiments, or to some or all of the technical features It is equivalently replaced;And these are modified or replaceed, various embodiments of the present invention skill that it does not separate the essence of the corresponding technical solution The range of art scheme.

Claims (10)

1. the culture medium that a kind of inducing umbilical cord mesenchymal stem breaks up at rouge, which is characterized in that its by basal medium extremely Following component is additionally added less to obtain:
0.7~1.3 μm of ol/L of dexamethasone, 400~600 μm of ol/L, IBMX0.3~0.7mmol/L of Indomethacin, insulin 7 40~60 μ g/mL of~13 μm of ol/L and acid ascorbyl ester.
2. culture medium according to claim 1, which is characterized in that it is by addition such as the following group at least additional in basal medium Get:
0.8~1.2 μm of ol/L of dexamethasone, 450~550 μm of ol/L, IBMX0.4~0.6mmol/L of Indomethacin, insulin 8 45~55 μ g/mL of~12 μm of ol/L and acid ascorbyl ester.
3. culture medium according to claim 1, which is characterized in that it is by addition such as the following group at least additional in basal medium Get:
1 μm of ol/L of dexamethasone, 500 μm of ol/L, IBMX0.5mmol/L of Indomethacin, 10 μm of ol/L of insulin and Vitamin C 50 μ g/mL of acid esters.
4. described in any item culture mediums according to claim 1~3, which is characterized in that the basal medium is DMEM low sugar Culture medium;
Preferably, the glutamine containing 8%~12%FBS and 0.08%~0.12% in the DMEM low sugar culture medium.
5. a kind of inducing umbilical cord mesenchymal stem is at rouge differentiation method characterized by comprising
Use the described in any item culture medium culture umbilical cord mesenchymal stem cells of Claims 1 to 44.
6. according to the method described in claim 5, it is characterized in that, the umbilical cord mesenchymal stem cells for inoculation are P3~P5 In generation, cell confluency degree is 70%~80% and cell in good condition is collected after digesting and obtained.
7. according to the method described in claim 6, it is characterized in that, pancreas enzyme concentration used by the digestion be 0.20%~ 0.30%.
8. after cleaning cell, cell is moved to ventilative the method according to the description of claim 7 is characterized in that being completed in digestion In sharp floor cells culture tube, supernatant liquid is removed after centrifugation.
9. according to the method described in claim 5, it is characterized in that, the inoculum concentration of cell is that every 2mL culture medium connects in culture Kind (1~5) × 104A cell.
10. according to the method described in claim 5, it is characterized in that, the time of the culture is 12~14 days;Preferably, every 2 It changes the liquid once within~4 days.
CN201811410285.0A 2018-11-23 2018-11-23 Culture medium used in the cultural method and this method that inducing umbilical cord mesenchymal stem breaks up at rouge Pending CN109355253A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811410285.0A CN109355253A (en) 2018-11-23 2018-11-23 Culture medium used in the cultural method and this method that inducing umbilical cord mesenchymal stem breaks up at rouge

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811410285.0A CN109355253A (en) 2018-11-23 2018-11-23 Culture medium used in the cultural method and this method that inducing umbilical cord mesenchymal stem breaks up at rouge

Publications (1)

Publication Number Publication Date
CN109355253A true CN109355253A (en) 2019-02-19

Family

ID=65338609

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811410285.0A Pending CN109355253A (en) 2018-11-23 2018-11-23 Culture medium used in the cultural method and this method that inducing umbilical cord mesenchymal stem breaks up at rouge

Country Status (1)

Country Link
CN (1) CN109355253A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111172101A (en) * 2019-12-31 2020-05-19 上海林望生物科技有限公司 Method for inducing and differentiating human pluripotent stem cells into adipocytes

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110104133A1 (en) * 2008-05-06 2011-05-05 Joslin Diabetes Center, Inc. Methods and compositions for inducing brown adipogenesis
CN104830757A (en) * 2015-04-15 2015-08-12 广州赛莱拉干细胞科技股份有限公司 Mesenchymal stem cell adipogenic induced differentiation culture medium and preparation method thereof
WO2017009263A1 (en) * 2015-07-10 2017-01-19 Etablissement Francais Du Sang Method for obtaining human brown/beige adipocytes
CN107267450A (en) * 2017-08-08 2017-10-20 成都源泉生物科技有限公司 A kind of adult stem cell adipogenic induction culture medium
CN108588015A (en) * 2018-03-06 2018-09-28 安徽瑞杰赛尔生物科技有限公司 A kind of human mesenchymal stem cell adipogenic induction differential medium and preparation method

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110104133A1 (en) * 2008-05-06 2011-05-05 Joslin Diabetes Center, Inc. Methods and compositions for inducing brown adipogenesis
CN104830757A (en) * 2015-04-15 2015-08-12 广州赛莱拉干细胞科技股份有限公司 Mesenchymal stem cell adipogenic induced differentiation culture medium and preparation method thereof
WO2017009263A1 (en) * 2015-07-10 2017-01-19 Etablissement Francais Du Sang Method for obtaining human brown/beige adipocytes
CN107267450A (en) * 2017-08-08 2017-10-20 成都源泉生物科技有限公司 A kind of adult stem cell adipogenic induction culture medium
CN108588015A (en) * 2018-03-06 2018-09-28 安徽瑞杰赛尔生物科技有限公司 A kind of human mesenchymal stem cell adipogenic induction differential medium and preparation method

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
唐军 等: "低氧对人脐带间充质干细胞成脂肪分化的影响", 《中国美容医学》 *
汪兆艳 等: "人脐带源间充质干细胞体外成脂、成骨、成软骨诱导分化", 《转化医学杂志》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111172101A (en) * 2019-12-31 2020-05-19 上海林望生物科技有限公司 Method for inducing and differentiating human pluripotent stem cells into adipocytes

Similar Documents

Publication Publication Date Title
CN101748096B (en) Sub totipotential stem cell and preparation method and application thereof
CN104450611B (en) A kind of primary isolation and culture method of human amnion mesenchymal stem cell
CN102367435B (en) Preparation of human platelet-rich plasma and application of same in isolation and culture of human mesenchymal stem cells
CN102978156A (en) Expansion in vitro purification culture method of mesenchymal stem cells and culture medium
CN109456939A (en) Culture medium used in cultural method and this method of the inducing umbilical cord mesenchymal stem at cartilage differentiation
CN104762257B (en) A kind of method preparing mescenchymal stem cell from umbilical cord
CN109234229A (en) Method and digestive enzyme compositions used from placenta blood vessel separating mesenchymal stem cell
CN105039248B (en) Tree shrew mesenchymal stem cell culture systems
CN109988746A (en) A kind of mescenchymal stem cell adipogenic induction differentiation method
CN105087474A (en) Culture method of deciduous tooth pulp stem cells
CN105850979A (en) Cryoprotective solution and cryopreservation method for bone mesenchymal stem cells
CN105062970B (en) A kind of derivant and induction differentiation complete medium that mescenchymal stem cell is induced to neuroblast
CN106754685A (en) A kind of construction method of Human fat mesenchymal stem cell bank
CN106119191A (en) A kind of placental villi plate mescenchymal stem cell and clinicization preparation method
CN107287156A (en) A kind of isolated culture method of fat mesenchymal stem cell and its application
CN109628388B (en) Isolation of mesenchymal stem cells from placental blood vessels with digestive enzyme composition
CN104450610B (en) Subculture method of human amniotic mesenchymal stem cells
CN107236705B (en) Human placenta chorion mesenchymal stem cell culture system
CN109355253A (en) Culture medium used in the cultural method and this method that inducing umbilical cord mesenchymal stem breaks up at rouge
CN104031881B (en) A kind of isolated culture method of mankind's olfactory mucosa mescenchymal stem cell
CN107287158A (en) The method of effective acquisition mescenchymal stem cell from mouse dense bone
CN102703380B (en) Sub-totipotent stem cell, preparation method and application thereof
CN106032529A (en) Method for in-vitro separation, amplification and induced differentiation of placenta-derived mesenchymal stem cells
CN108495924A (en) Method for generating mescenchymal stem cell
CN108774630A (en) A kind of primary culture method of Microhyla ornata Skeletal Muscle Cell

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information
CB02 Change of applicant information

Address after: Room D409, floor 4, building 1, No. 12, Shangdi Information Road, Haidian District, Beijing 100000

Applicant after: Beijing Taidong Biotechnology Co., Ltd.

Address before: 100000 Floor C54, No. 19, Yufangyuan District, Fengtai District, Beijing

Applicant before: Beijing Taidong Biotechnology Co., Ltd.

RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20190219